S. Holzer et al., Patterns of care for patients with primary differentiated carcinoma of thethyroid gland treated in Germany during 1996, CANCER, 89(1), 2000, pp. 192-201
BACKGROUND. To determine current patterns of care and disease characteristi
cs for patients with thyroid carcinoma, a Patient Care Evaluation Study was
initiated in 1996 in the U.S. and Germany. This project addresses ongoing
concerns with respect to the diagnostic evaluation and treatment of patient
s diagnosed with thyroid carcinoma and raises questions concerning how phys
icians are interpreting current standards and acting on the basis of these
recommendations. METHODS. Patients with primary thyroid carcinoma were ente
red into a prospective multicenter observational study with free choice of
treatment (no control group) between January 1, 1996 and December 31, 1996
in Germany. This resulted in a total of 2537 cases under observation and an
alysis; 1685 patients had papillary carcinoma (66.4%), 691 had follicular c
arcinoma (27.2%), 70 had medullary carcinoma (2.8%), and 91 had anaplastic
carcinoma (3.6%). The 2376 patients with carcinoma of either papillary or f
ollicular histology were included in the current analysis. RESULTS. The maj
or symptoms reported for patients with papillary and follicular thyroid car
cinoma was neck mass (reported in 76% and 79%, respectively) followed by dy
sphagia (reported in 25% and 27%, respectively), strider (reported in 9% an
d 14%, respectively), and neck pain (reported in 7% and 8%, respectively).
Greater than 50% of the patients with papillary thyroid carcinoma were repo
rted to have American Joint Committee on Cancer/International Union Against
Cancer Stage I disease. Between 37-39% of the follicular carcinoma patient
s had Stage I and Stage II disease. Only slight differences in the diagnost
ic approach to patients with papillary or follicular carcinoma were noted.
The majority of patients underwent an ultrasound of the thyroid region (78.
1%), which was suggestive of carcinoma in only 39% of the cases. A thyroid
scan was performed on 76.6% of patients, and the results were suggestive of
carcinoma in 44.8% of the individuals. In contrast, fine-needle aspiration
biopsy of the thyroid is highly recommended in the current Clinical Practi
ce Guidelines (CPG) but results were obtained in only 27.4% of the patients
. Total thyroidectomy without lymph node dissection was the most commonly u
sed surgical procedure in the treatment of patients with papillary and foll
icular thyroid carcinoma. Only approximately 2% of patients at low risk in
the group with Stage I disease were treated with a lobectomy. In 80% of the
patients with Stage I papillary thyroid carcinoma and approximately 90% of
those patients diagnosed with Stage II, III, and IV disease treating physi
cians chose to utilize radioiodine as adjuvant treatment after disease-dire
cted surgery. External beam radiation was added to the treatment regimen fo
r many patients diagnosed with Stage III and IV disease (30% in patients wi
th papillary thyroid carcinoma and 33% in patients with follicular thyroid
carcinoma). CONCLUSIONS. To the authors' knowledge no single effective diag
nostic test for thyroid carcinoma currently is available and in the majorit
y of cases a combination of ultrasound, thyroid scan, or fine-needle aspira
tion biopsy together with the clinical findings (e.g., thyroid mass) led to
a diagnosis of carcinoma. The authors suspect that the high prevalence of
concomitant pathologic findings such as goiter, even in the healthy populat
ion in Germany, reduces the accuracy of all diagnostic test methods and may
account for the frequent use of imaging techniques. The majority of patien
ts underwent a total or near-total thyroidectomy. Total thyroidectomy with
radical lymph node dissection was used very frequently in those patients wi
th papillary thyroid carcinoma (22%).
German physicians tend to surgically treat early stage thyroid carcinoma so
mewhat more radically than recommended in the CPG. With respect to other tr
eatment options employed as part of the first course of treatment, radioiod
ine appears to play the most important role. [See commentary on pages 1-4,
this issue and communication on pages 202-17, this issue.] (C) 2000 America
n Cancer Society.